Stay updated on JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial
Sign up to get notified when there's something new on the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page.

Latest updates to the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page
- Check3 days agoChange DetectedUpdated to v3.0.2 from v3.0.1 and removed the Back to Top element. This is a minor release with no changes to core content, pricing, stock, or time-sensitive information.SummaryDifference0.1%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to drug safety and counterfeit drugs. The previous version's specific location details and certain medical terms have been removed.SummaryDifference1%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check39 days agoChange DetectedThe web page has been updated to version 2.16.11, and a service alert regarding planned maintenance has been removed.SummaryDifference0.6%
- Check54 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.1%
Stay in the know with updates to JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page.